FDA Approves Atripla, Once Daily Single Tablet AIDS Drug
Filed in archive Drugs, Vaccines and Therapeutics by ruth on July 14, 2006

transcriptase, an enzyme HIV needs to replicate. Certainly not a real breakthrough, but might mean more compliance from AIDS patients. According to the manufacturers, Atripla will cost $1,150.88 for a 30-day supply. No price has been set for developing countries. A similar three-in-one AIDS pill produced by India-based Aurobindo Pharma has also been previously approved. However, this version, which is not sold in the US, contains generic versions of older HIV drugs.
More details from Reuters and from the press releases from Gilead and BMS.
Permalink: FDA Approves Atripla, Once Daily Single Tablet AIDS Drug
Tags:
AIDS
HIV
aids
biotech
drug
aids+drug
approves+atripla
single+tablet
Trackback: http://www.creative-weblogging.com/cgi-bin/mt-tb.pl/29269

Mr Wong
